Physician_Profile_ID,Category,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Category,Record_ID
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,133.33,04/22/2015,GNRL,260093890
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,125.00,09/23/2014,GNRL,156934368
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,123.04,01/14/2015,GNRL,260051158
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,119.70,02/11/2015,GNRL,260082480
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,112.38,10/07/2015,GNRL,318903988
62683,GNRL,"Purdue Pharma L.P.",CT,100000005432,99.98,03/11/2015,GNRL,251005926
62683,GNRL,"Astellas Pharma US Inc",IL,100000000137,99.00,12/19/2013,GNRL,111735648
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,97.12,12/10/2014,GNRL,194795182
62683,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,90.90,03/12/2014,GNRL,187800250
62683,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,89.23,01/29/2014,GNRL,187751608
62683,GNRL,"Astellas Pharma US Inc",IL,100000000137,88.75,07/08/2015,GNRL,294814608
62683,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,82.66,10/02/2013,GNRL,13969965
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,77.89,02/12/2014,GNRL,150682270
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,75.20,08/12/2014,GNRL,162182048
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,74.99,07/18/2014,GNRL,156934356
62683,GNRL,"VIVUS, Inc.",CA,100000005620,73.64,09/25/2013,GNRL,27276629
62683,GNRL,"Astellas Pharma US Inc",IL,100000000137,72.51,09/10/2014,GNRL,168837830
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,69.00,10/02/2014,GNRL,156934370
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,69.00,11/03/2014,GNRL,194795118
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,69.00,01/26/2015,GNRL,336836150
62683,GNRL,"AbbVie, Inc.",IL,100000000204,67.60,02/13/2014,GNRL,189174590
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,61.04,04/06/2015,GNRL,319267949
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,58.99,10/28/2015,GNRL,270188616
62683,GNRL,"Pfizer Inc.",NY,100000000286,42.14,12/11/2013,GNRL,206083732
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,41.02,08/23/2013,GNRL,104459118
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,30.25,12/02/2015,GNRL,318717658
62683,GNRL,"LILLY USA, LLC",IN,100000000066,29.22,12/16/2013,GNRL,100092146
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,26.78,08/15/2014,GNRL,196403298
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,25.54,01/16/2014,GNRL,196403092
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,24.23,02/25/2014,GNRL,196403076
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,23.54,09/18/2015,GNRL,260054636
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,23.34,09/08/2014,GNRL,196403286
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,22.29,04/28/2015,GNRL,290546296
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,21.71,03/24/2014,GNRL,196403070
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,21.63,01/29/2015,GNRL,260021002
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,21.15,05/08/2014,GNRL,196403056
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,20.12,05/08/2015,GNRL,269699912
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,19.58,10/15/2015,GNRL,319489569
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,19.51,03/05/2015,GNRL,290546304
62683,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,19.49,01/28/2014,GNRL,187747320
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,19.37,03/11/2015,GNRL,339771062
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,19.13,01/05/2015,GNRL,339746172
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,19.11,06/28/2014,GNRL,199570512
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,18.98,02/12/2015,GNRL,260109594
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,18.97,10/22/2015,GNRL,290546384
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,18.54,03/13/2014,GNRL,196403072
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,18.19,10/05/2015,GNRL,339665068
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,18.10,07/10/2014,GNRL,196805422
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,17.88,02/17/2015,GNRL,337055478
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,17.80,06/26/2014,GNRL,150864985
62683,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,17.74,02/28/2014,GNRL,163248148
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,17.51,08/06/2015,GNRL,275869554
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,17.45,11/19/2014,GNRL,149740532
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,17.42,08/31/2015,GNRL,339632210
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,17.37,01/23/2015,GNRL,290546314
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,17.12,07/14/2015,GNRL,260095534
62683,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,17.04,05/27/2015,GNRL,283338020
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,17.02,06/30/2015,GNRL,337239278
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.93,06/01/2015,GNRL,260122554
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,16.79,12/12/2014,GNRL,196403254
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.66,12/03/2015,GNRL,260102670
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,16.62,10/17/2013,GNRL,25369349
62683,GNRL,"AbbVie, Inc.",IL,100000000204,16.62,10/26/2015,GNRL,317274243
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,16.53,04/22/2015,GNRL,290140460
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,16.48,09/30/2015,GNRL,290546264
62683,GNRL,"AbbVie, Inc.",IL,100000000204,16.39,10/06/2013,GNRL,31116557
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.39,07/17/2014,GNRL,148715170
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,16.33,09/04/2015,GNRL,275869556
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,16.29,10/19/2015,GNRL,275869580
62683,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,16.26,10/29/2015,GNRL,321146075
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,16.15,06/12/2015,GNRL,290546290
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,16.09,09/20/2013,GNRL,100815840
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.05,03/19/2014,GNRL,149795576
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.91,07/28/2015,GNRL,269886448
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,15.81,05/07/2015,GNRL,275869572
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,15.72,11/16/2015,GNRL,275869564
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.66,09/21/2015,GNRL,270002974
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,15.61,07/29/2015,GNRL,290546280
62683,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,15.50,11/05/2014,GNRL,198507700
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.48,03/17/2015,GNRL,269652276
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.44,06/19/2014,GNRL,149352204
62683,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,15.36,12/05/2013,GNRL,24056703
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,15.33,02/18/2015,GNRL,290546308
62683,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,15.29,10/24/2013,GNRL,12883388
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,15.28,10/03/2013,GNRL,104412268
62683,GNRL,"Eisai Inc.",NJ,100000000136,15.28,06/25/2014,GNRL,184547812
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.25,05/02/2014,GNRL,148567128
62683,GNRL,"Pfizer Inc.",NY,100000000286,15.23,09/15/2014,GNRL,205755374
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,15.21,02/07/2014,GNRL,196403080
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.20,06/09/2015,GNRL,269780598
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,15.19,05/02/2014,GNRL,199570510
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,15.15,11/25/2015,GNRL,275869550
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,15.08,10/23/2015,GNRL,290546388
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,15.05,08/20/2014,GNRL,196403294
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.02,10/16/2015,GNRL,260028854
62683,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,14.98,03/27/2015,GNRL,321093316
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.87,07/01/2015,GNRL,290546286
62683,GNRL,"Pfizer Inc.",NY,100000000286,14.87,09/23/2015,GNRL,323386318
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.81,01/12/2015,GNRL,269625547
62683,GNRL,"Pfizer Inc.",NY,100000000286,14.80,11/23/2015,GNRL,323953764
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.78,03/27/2014,GNRL,149952518
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,14.64,04/24/2014,GNRL,194795176
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.64,06/11/2015,GNRL,260118372
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.63,02/28/2014,GNRL,196803868
62683,GNRL,"Pfizer Inc.",NY,100000000286,14.60,12/11/2014,GNRL,206982474
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.58,11/25/2014,GNRL,196403262
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.54,02/09/2015,GNRL,269571004
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.53,09/23/2013,GNRL,104401142
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.52,02/05/2015,GNRL,290546310
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,14.45,12/03/2013,GNRL,100876396
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.44,07/15/2014,GNRL,196805350
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.28,03/16/2015,GNRL,260048796
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,14.27,05/18/2015,GNRL,339454022
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.21,01/30/2014,GNRL,160809992
62683,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,14.21,04/08/2015,GNRL,283337938
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.19,11/19/2014,GNRL,149909814
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.19,07/09/2015,GNRL,269827798
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.18,03/12/2015,GNRL,260099388
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.09,04/28/2014,GNRL,196804334
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,14.07,12/04/2015,GNRL,339440684
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,14.00,11/24/2014,GNRL,147123763
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,13.98,08/05/2013,GNRL,100859688
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.98,09/11/2015,GNRL,290546268
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.96,06/23/2015,GNRL,269766852
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.96,04/13/2015,GNRL,269661212
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.92,09/18/2014,GNRL,196403281
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.92,12/14/2015,GNRL,290546392
62683,GNRL,"Pfizer Inc.",NY,100000000286,13.92,03/18/2015,GNRL,322913178
62683,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,13.91,12/17/2014,GNRL,248162930
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.89,07/16/2015,GNRL,275869576
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.77,09/26/2014,GNRL,150264630
62683,GNRL,"Eisai Inc.",NJ,100000000136,13.77,07/23/2014,GNRL,184547810
62683,GNRL,"Abbott Laboratories",IL,100000010680,13.76,08/01/2013,GNRL,22880959
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.73,12/10/2014,GNRL,149196280
62683,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,13.73,08/11/2014,GNRL,163225910
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.73,10/21/2015,GNRL,270022072
62683,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,13.73,12/10/2015,GNRL,283377960
62683,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,13.67,11/19/2013,GNRL,14033208
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,13.64,08/29/2013,GNRL,100876394
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.57,04/02/2014,GNRL,196804082
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.56,10/09/2015,GNRL,275869562
62683,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,13.52,05/23/2014,GNRL,163286144
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.52,11/09/2015,GNRL,270101990
62683,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,13.49,07/09/2014,GNRL,163256514
62683,GNRL,"Pfizer Inc.",NY,100000000286,13.49,01/13/2015,GNRL,323842698
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.45,12/17/2014,GNRL,148215742
62683,GNRL,"Pfizer Inc.",NY,100000000286,13.45,11/03/2014,GNRL,206512140
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,13.41,11/14/2013,GNRL,171970908
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.41,07/22/2014,GNRL,196805358
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.41,09/03/2015,GNRL,290546272
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,13.33,06/06/2014,GNRL,199570508
62683,GNRL,"Impax Laboratories, Inc.",CA,100000010694,13.29,09/25/2013,GNRL,31719144
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.29,03/10/2014,GNRL,150925524
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,13.29,09/23/2015,GNRL,319721674
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.28,08/25/2015,GNRL,290546274
62683,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,13.24,09/17/2013,GNRL,14033207
62683,GNRL,"Pfizer Inc.",NY,100000000286,13.22,03/13/2015,GNRL,322690348
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.20,11/22/2013,GNRL,104379150
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,13.20,11/11/2014,GNRL,194795116
62683,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,13.16,08/02/2013,GNRL,31902921
62683,GNRL,"Pfizer Inc.",NY,100000000286,13.15,07/31/2014,GNRL,206151282
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.09,10/13/2015,GNRL,290546258
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.06,05/14/2014,GNRL,150614844
62683,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,13.04,08/26/2015,GNRL,321146054
62683,GNRL,"Iroko Pharmaceuticals, LLC",PA,100000011114,13.00,07/25/2014,GNRL,227796784
62683,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,13.00,08/26/2015,GNRL,283338022
62683,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,12.99,09/02/2015,GNRL,283338024
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,12.97,06/23/2014,GNRL,196403318
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.96,01/20/2014,GNRL,196803516
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.96,05/04/2015,GNRL,269701414
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.93,12/08/2015,GNRL,270110066
62683,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,12.87,05/06/2015,GNRL,283338018
62683,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,12.83,07/30/2014,GNRL,187992726
62683,GNRL,"Amgen Inc.",CA,100000000203,12.81,01/09/2014,GNRL,138155548
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,12.74,03/14/2014,GNRL,194795074
62683,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,12.70,02/24/2015,GNRL,321146002
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.65,05/20/2015,GNRL,260124842
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.64,10/17/2013,GNRL,23817096
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,12.64,04/10/2015,GNRL,339359764
62683,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,12.63,01/14/2015,GNRL,283337936
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.62,03/05/2014,GNRL,196803284
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,12.62,04/27/2014,GNRL,199570505
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.62,01/21/2015,GNRL,260113090
62683,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,12.49,10/07/2015,GNRL,283403088
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.44,08/30/2013,GNRL,12124942
62683,GNRL,"Pfizer Inc.",NY,100000000286,12.44,05/22/2015,GNRL,323514196
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.40,11/25/2015,GNRL,270172142
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,12.38,04/14/2015,GNRL,337094446
62683,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,12.37,08/18/2014,GNRL,198507704
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.33,01/06/2014,GNRL,196803556
62683,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,12.29,10/08/2014,GNRL,217619978
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.28,09/09/2015,GNRL,260115342
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.26,01/15/2015,GNRL,260028690
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,12.25,08/13/2015,GNRL,290546278
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.20,04/16/2015,GNRL,275869568
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,12.19,09/08/2015,GNRL,339331764
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,12.15,07/31/2015,GNRL,290546382
62683,GNRL,"Astellas Pharma US Inc",IL,100000000137,12.12,10/16/2013,GNRL,111784580
62683,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,12.12,07/01/2014,GNRL,217619980
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,12.12,05/30/2014,GNRL,194795094
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.12,05/27/2015,GNRL,269742513
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.12,12/16/2015,GNRL,270246146
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,12.10,09/25/2015,GNRL,290546266
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.07,03/26/2015,GNRL,260099982
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,12.06,06/02/2014,GNRL,194795090
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,12.04,10/20/2015,GNRL,339315958
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,12.04,10/20/2015,GNRL,339315962
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.99,04/23/2015,GNRL,337106044
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.98,10/28/2015,GNRL,260030590
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.96,10/20/2014,GNRL,196403270
62683,GNRL,"Astellas Pharma US Inc",IL,100000000137,11.94,07/13/2015,GNRL,294708676
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.91,11/14/2013,GNRL,32332114
62683,GNRL,"AbbVie, Inc.",IL,100000000204,11.90,11/18/2013,GNRL,31116558
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.89,04/29/2014,GNRL,196403064
62683,GNRL,"AbbVie, Inc.",IL,100000000204,11.81,10/02/2014,GNRL,189529428
62683,GNRL,"Pfizer Inc.",NY,100000000286,11.80,06/13/2014,GNRL,207032848
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.80,11/12/2015,GNRL,290140462
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,11.75,11/07/2013,GNRL,100859690
62683,GNRL,"AbbVie, Inc.",IL,100000000204,11.73,07/08/2014,GNRL,189399966
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.72,08/26/2014,GNRL,194795070
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.66,08/27/2014,GNRL,196695626
62683,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,11.66,06/18/2014,GNRL,217619984
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.60,10/27/2015,GNRL,290546256
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,11.58,03/26/2014,GNRL,199570502
62683,GNRL,"Astellas Pharma US Inc",IL,100000000137,11.57,05/15/2014,GNRL,168536568
62683,GNRL,"Grifols USA, LLC",CA,100000005420,11.57,12/16/2014,GNRL,220249976
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.54,04/17/2014,GNRL,196403068
62683,GNRL,"Pfizer Inc.",NY,100000000286,11.54,04/17/2015,GNRL,323134218
62683,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,11.48,06/10/2014,GNRL,187918828
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.44,07/15/2015,GNRL,269885666
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,11.42,10/10/2014,GNRL,199570498
62683,GNRL,"Pfizer Inc.",NY,100000000286,11.37,11/19/2014,GNRL,207231090
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.36,07/24/2015,GNRL,260118018
62683,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,11.35,06/29/2015,GNRL,321146037
62683,GNRL,"Pfizer Inc.",NY,100000000286,11.30,10/27/2014,GNRL,206638006
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.28,08/20/2013,GNRL,12157314
62683,GNRL,"Purdue Pharma L.P.",CT,100000005432,11.26,10/03/2014,GNRL,158149096
62683,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,11.23,06/20/2014,GNRL,173038294
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.22,10/29/2014,GNRL,196403266
62683,GNRL,"Lilly USA, LLC",IN,100000000066,11.13,04/03/2015,GNRL,268197624
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.12,03/23/2015,GNRL,337043162
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.09,03/30/2015,GNRL,337049154
62683,GNRL,"Pfizer Inc.",NY,100000000286,11.00,11/10/2014,GNRL,206441754
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,10.99,11/21/2014,GNRL,199570494
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.99,12/29/2014,GNRL,196403252
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.98,09/25/2014,GNRL,196403278
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.96,09/24/2013,GNRL,32332113
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.94,05/29/2014,GNRL,196403330
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,10.91,08/14/2014,GNRL,156934372
62683,GNRL,"Takeda Pharmaceuticals U.S.A., Inc.",IL,100000000337,10.89,10/14/2014,GNRL,194795122
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.89,12/15/2015,GNRL,260119684
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.87,03/25/2014,GNRL,148275466
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,10.87,08/05/2015,GNRL,339209226
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.84,09/17/2014,GNRL,150919736
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.84,11/12/2014,GNRL,196807054
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.84,08/06/2014,GNRL,196805600
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.83,01/28/2015,GNRL,290546312
62683,GNRL,"Astellas Pharma US Inc",IL,100000000137,10.83,04/30/2015,GNRL,295152594
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,10.82,06/24/2015,GNRL,339201054
62683,GNRL,"Pfizer Inc.",NY,100000000286,10.80,12/30/2013,GNRL,205255065
62683,GNRL,"Pfizer Inc.",NY,100000000286,10.80,07/18/2014,GNRL,207001374
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.79,05/05/2014,GNRL,194795086
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.73,08/13/2014,GNRL,196403302
62683,GNRL,"Pfizer Inc.",NY,100000000286,10.71,10/02/2013,GNRL,205871987
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.69,08/25/2013,GNRL,32332115
62683,GNRL,"Purdue Pharma L.P.",CT,100000005432,10.68,12/07/2015,GNRL,251154126
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.66,04/30/2014,GNRL,194795082
62683,GNRL,"Pfizer Inc.",NY,100000000286,10.65,01/23/2015,GNRL,323528968
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.62,11/20/2013,GNRL,25369352
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.59,05/28/2014,GNRL,149458512
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.57,08/12/2015,GNRL,290140458
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,10.56,09/24/2014,GNRL,199570491
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.56,06/03/2015,GNRL,260072396
62683,GNRL,"Pfizer Inc.",NY,100000000286,10.55,12/23/2015,GNRL,323528614
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,10.44,09/09/2014,GNRL,156934364
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.43,05/06/2015,GNRL,260030208
62683,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,10.43,03/19/2015,GNRL,321146012
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,10.42,09/15/2015,GNRL,275869560
62683,GNRL,"Pfizer Inc.",NY,100000000286,10.39,06/06/2015,GNRL,323058662
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,10.39,11/16/2015,GNRL,319377670
62683,GNRL,"Pfizer Inc.",NY,100000000286,10.38,04/11/2014,GNRL,207236328
62683,GNRL,"Amgen Inc.",CA,100000000203,10.37,08/04/2014,GNRL,138155550
62683,GNRL,"Astellas Pharma US Inc",IL,100000000137,10.37,04/22/2014,GNRL,168498003
62683,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,10.36,01/28/2015,GNRL,321145996
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,10.35,04/12/2014,GNRL,199570488
62683,GNRL,"Pfizer Inc.",NY,100000000286,10.34,10/14/2014,GNRL,206844660
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.34,12/17/2014,GNRL,196695622
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,10.30,09/24/2015,GNRL,319636402
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,10.29,08/24/2015,GNRL,326181778
62683,GNRL,"Pfizer Inc.",NY,100000000286,10.27,07/09/2015,GNRL,322986264
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.26,07/29/2014,GNRL,196403310
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,10.15,04/02/2015,GNRL,339148044
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.14,10/17/2014,GNRL,196695624
62683,GNRL,"Pfizer Inc.",NY,100000000286,10.13,11/01/2013,GNRL,205498444
62683,GNRL,"Pfizer Inc.",NY,100000000286,10.11,08/20/2014,GNRL,206662382
62683,GNRL,"Astellas Pharma US Inc",IL,100000000137,10.10,08/22/2013,GNRL,111799056
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.08,08/07/2014,GNRL,194795166
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.00,12/16/2013,GNRL,25369354
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.00,01/24/2014,GNRL,196403090
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.00,10/27/2014,GNRL,194795112
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,9.97,05/12/2014,GNRL,156934348
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,9.96,11/02/2015,GNRL,339142282
62683,GNRL,"Pfizer Inc.",NY,100000000286,9.94,10/28/2013,GNRL,205224086
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,9.91,12/17/2015,GNRL,290546390
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,9.91,04/20/2015,GNRL,319139599
62683,GNRL,"Pfizer Inc.",NY,100000000286,9.88,09/12/2014,GNRL,206257268
62683,GNRL,"Pfizer Inc.",NY,100000000286,9.85,10/15/2015,GNRL,323393716
62683,GNRL,"Pfizer Inc.",NY,100000000286,9.84,02/06/2015,GNRL,322721512
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,9.81,02/18/2015,GNRL,269610922
62683,GNRL,"Pfizer Inc.",NY,100000000286,9.76,05/11/2015,GNRL,322534322
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,9.75,08/11/2015,GNRL,337299316
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,9.72,12/17/2013,GNRL,104312572
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,9.68,08/08/2014,GNRL,156934358
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,9.68,06/04/2014,GNRL,196403324
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,9.63,10/09/2014,GNRL,194795064
62683,GNRL,"Pfizer Inc.",NY,100000000286,9.62,12/09/2014,GNRL,206772266
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,9.58,10/08/2013,GNRL,25369346
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,9.58,04/16/2014,GNRL,196804396
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,9.54,05/28/2015,GNRL,319248990
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,9.53,12/02/2015,GNRL,339129086
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,9.48,09/13/2013,GNRL,104310836
62683,GNRL,"Astellas Pharma US Inc",IL,100000000137,9.47,11/18/2015,GNRL,295073320
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,9.40,03/10/2015,GNRL,318637256
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,9.37,07/09/2014,GNRL,196805426
62683,GNRL,"Astellas Pharma US Inc",IL,100000000137,9.34,10/07/2014,GNRL,168433352
62683,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,9.27,02/03/2014,GNRL,187762406
62683,GNRL,"Pfizer Inc.",NY,100000000286,9.26,02/11/2014,GNRL,206679272
62683,GNRL,"Pfizer Inc.",NY,100000000286,9.24,08/03/2015,GNRL,322438388
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,9.19,03/05/2014,GNRL,194795152
62683,GNRL,"Astellas Pharma US Inc",IL,100000000137,9.17,09/30/2013,GNRL,111778916
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,9.16,01/23/2014,GNRL,156934334
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,9.16,07/29/2015,GNRL,319454088
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,9.15,11/04/2015,GNRL,290546252
62683,GNRL,"Astellas Pharma US Inc",IL,100000000137,9.11,08/27/2015,GNRL,294949042
62683,GNRL,"Pfizer Inc.",NY,100000000286,9.10,05/20/2014,GNRL,206599146
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,8.98,02/02/2015,GNRL,319169696
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.96,10/29/2014,GNRL,196807108
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,8.96,07/08/2015,GNRL,290546282
62683,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,8.95,03/25/2015,GNRL,321146022
62683,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,8.94,11/24/2015,GNRL,321146100
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,8.93,05/27/2014,GNRL,196403334
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.92,05/20/2015,GNRL,330529845
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,8.87,07/23/2015,GNRL,339102444
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,8.79,05/19/2015,GNRL,319541250
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.76,02/19/2014,GNRL,196803340
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,8.75,03/05/2015,GNRL,290546302
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,8.69,11/27/2014,GNRL,199570482
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,8.68,10/15/2015,GNRL,339096160
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,8.67,02/19/2015,GNRL,290546306
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,8.67,09/17/2015,GNRL,337340490
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,8.64,12/02/2015,GNRL,290546396
62683,GNRL,"Pfizer Inc.",NY,100000000286,8.63,09/23/2014,GNRL,206285768
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,8.60,11/25/2014,GNRL,194795138
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,8.53,02/14/2014,GNRL,194795148
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,8.47,01/16/2014,GNRL,156934332
62683,GNRL,"Astellas Pharma US Inc",IL,100000000137,8.43,02/13/2014,GNRL,168480090
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.41,07/01/2015,GNRL,269968148
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,8.40,03/10/2014,GNRL,147123692
62683,GNRL,"Pfizer Inc.",NY,100000000286,8.37,03/24/2015,GNRL,322626350
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.34,03/31/2015,GNRL,330347961
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,8.32,03/06/2014,GNRL,156934340
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,8.30,08/04/2014,GNRL,194795168
62683,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,8.29,09/30/2015,GNRL,321146062
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.27,03/05/2015,GNRL,330227999
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.20,11/30/2015,GNRL,331085871
62683,GNRL,"Pfizer Inc.",NY,100000000286,8.16,06/09/2014,GNRL,206189372
62683,GNRL,"Astellas Pharma US Inc",IL,100000000137,8.12,03/25/2015,GNRL,295151595
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,8.04,08/02/2013,GNRL,25369350
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,8.01,02/20/2014,GNRL,147123680
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,7.96,05/09/2014,GNRL,147123768
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,7.96,08/20/2015,GNRL,290546276
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,7.86,01/21/2014,GNRL,200977704
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,7.82,12/30/2015,GNRL,339072222
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,7.75,02/02/2015,GNRL,339070512
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,7.71,10/02/2015,GNRL,290546260
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,7.68,03/09/2015,GNRL,337034082
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,7.66,11/11/2015,GNRL,290546404
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,7.55,12/11/2015,GNRL,337440334
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,7.49,12/03/2014,GNRL,199570480
62683,GNRL,"Pfizer Inc.",NY,100000000286,7.48,08/15/2013,GNRL,205779670
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,7.47,12/04/2014,GNRL,202576254
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,7.47,06/18/2015,GNRL,330639975
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,7.34,06/26/2014,GNRL,147123740
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,7.28,04/29/2015,GNRL,319063730
62683,GNRL,"LILLY USA, LLC",IN,100000000066,7.25,09/19/2013,GNRL,100148206
62683,GNRL,"Pfizer Inc.",NY,100000000286,7.25,07/24/2014,GNRL,206709114
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,7.23,12/22/2014,GNRL,202727030
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,7.18,12/23/2015,GNRL,319833710
62683,GNRL,"Pfizer Inc.",NY,100000000286,7.16,10/22/2015,GNRL,323668634
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,7.12,06/15/2015,GNRL,318950849
62683,GNRL,"Pfizer Inc.",NY,100000000286,7.11,08/12/2015,GNRL,323496504
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,7.09,06/25/2015,GNRL,290546288
62683,GNRL,"Purdue Pharma L.P.",CT,100000005432,7.08,02/04/2015,GNRL,251032358
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,7.03,02/05/2014,GNRL,194795144
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,7.00,07/07/2014,GNRL,196805356
62683,GNRL,"Pfizer Inc.",NY,100000000286,6.94,04/16/2014,GNRL,206633560
62683,GNRL,"Pfizer Inc.",NY,100000000286,6.82,12/19/2014,GNRL,206602018
62683,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,6.72,05/19/2015,GNRL,321146030
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,6.69,04/18/2014,GNRL,194795158
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,6.68,02/26/2015,GNRL,336903098
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,6.68,06/26/2015,GNRL,337239254
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,6.65,08/17/2015,GNRL,269964698
62683,GNRL,"Pfizer Inc.",NY,100000000286,6.65,11/09/2015,GNRL,323134330
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,6.65,01/28/2015,GNRL,319026263
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,6.61,09/11/2014,GNRL,194795102
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,6.61,07/30/2015,GNRL,269885010
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,6.55,01/16/2014,GNRL,196403098
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,6.55,01/26/2015,GNRL,336849942
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,6.54,06/24/2014,GNRL,201799100
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,6.49,06/10/2015,GNRL,330614703
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,6.48,04/07/2014,GNRL,196804430
62683,GNRL,"Pfizer Inc.",NY,100000000286,6.47,12/13/2013,GNRL,205453902
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,6.45,07/03/2015,GNRL,269799812
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,6.44,01/20/2015,GNRL,339037242
62683,GNRL,"LILLY USA, LLC",IN,100000000066,6.42,09/27/2013,GNRL,100124800
62683,GNRL,"Pfizer Inc.",NY,100000000286,6.42,10/03/2013,GNRL,205429532
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,6.42,11/06/2015,GNRL,337397808
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,6.40,01/29/2014,GNRL,196403086
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,6.40,04/09/2015,GNRL,290546300
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,6.37,10/22/2014,GNRL,194795134
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,6.33,02/18/2014,GNRL,201242518
62683,GNRL,"Pfizer Inc.",NY,100000000286,6.33,08/27/2015,GNRL,323671986
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,6.33,02/13/2015,GNRL,330174999
62683,GNRL,"Purdue Pharma L.P.",CT,100000005432,6.27,04/27/2015,GNRL,251072458
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,6.26,11/13/2015,GNRL,337408568
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,6.15,08/14/2013,GNRL,25369347
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,6.08,07/24/2014,GNRL,147123728
62683,GNRL,"Pfizer Inc.",NY,100000000286,6.03,12/18/2013,GNRL,205592698
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,6.02,04/24/2015,GNRL,290546298
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,5.96,03/03/2014,GNRL,201241836
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,5.93,07/20/2015,GNRL,330669857
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,5.90,09/30/2015,GNRL,318706849
62683,GNRL,"Pfizer Inc.",NY,100000000286,5.89,12/19/2013,GNRL,205411482
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,5.89,03/06/2014,GNRL,156934344
62683,GNRL,"Pfizer Inc.",NY,100000000286,5.89,02/11/2015,GNRL,323067750
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,5.88,11/20/2013,GNRL,25369355
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,5.84,01/07/2015,GNRL,336829786
62683,GNRL,"Pfizer Inc.",NY,100000000286,5.82,11/20/2015,GNRL,323298944
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,5.82,03/20/2015,GNRL,330259783
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,5.81,03/19/2014,GNRL,156934346
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,5.81,03/20/2014,GNRL,194795172
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,5.79,07/07/2014,GNRL,147123790
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,5.79,07/08/2015,GNRL,290546284
62683,GNRL,"Pfizer Inc.",NY,100000000286,5.77,09/16/2015,GNRL,323269906
62683,GNRL,"Horizon Pharma USA, Inc.",IL,100000005713,5.76,08/05/2013,GNRL,102011150
62683,GNRL,"Pfizer Inc.",NY,100000000286,5.74,11/13/2013,GNRL,205502744
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,5.72,02/24/2014,GNRL,147123786
62683,GNRL,"Pfizer Inc.",NY,100000000286,5.71,04/09/2015,GNRL,323399556
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,5.68,01/10/2014,GNRL,147123674
62683,GNRL,"LILLY USA, LLC",IN,100000000066,5.66,08/15/2013,GNRL,100157690
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,5.61,09/29/2014,GNRL,147123756
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,5.60,08/15/2014,GNRL,199570478
62683,GNRL,"Pfizer Inc.",NY,100000000286,5.57,05/16/2014,GNRL,206503550
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,5.57,02/20/2015,GNRL,336903076
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,5.54,08/29/2013,GNRL,25369348
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,5.54,06/26/2014,GNRL,156934354
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,5.52,06/04/2014,GNRL,201717294
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,5.50,09/18/2013,GNRL,25369351
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,5.49,09/24/2015,GNRL,269986052
62683,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,5.38,10/09/2014,GNRL,163253402
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,5.33,12/18/2014,GNRL,156934366
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,5.32,02/17/2014,GNRL,196803680
62683,GNRL,"Pfizer Inc.",NY,100000000286,5.32,05/13/2015,GNRL,323518572
62683,GNRL,"Pfizer Inc.",NY,100000000286,5.32,06/22/2015,GNRL,323058102
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,5.31,12/05/2013,GNRL,25369353
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,5.30,08/27/2015,GNRL,270010638
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,5.26,06/12/2014,GNRL,156934352
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,5.25,04/21/2015,GNRL,330448975
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,5.24,08/30/2013,GNRL,104293680
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,5.22,07/30/2015,GNRL,275869552
62683,GNRL,"Purdue Pharma L.P.",CT,100000005432,5.17,04/01/2015,GNRL,251060220
62683,GNRL,"Pfizer Inc.",NY,100000000286,5.16,08/10/2015,GNRL,323788938
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,5.14,08/13/2014,GNRL,196805998
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,5.10,03/12/2015,GNRL,330311219
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,5.02,09/17/2015,GNRL,330922799
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,4.97,12/03/2014,GNRL,196403258
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,4.97,05/14/2015,GNRL,330514661
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,4.96,08/14/2014,GNRL,201956262
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,4.89,06/16/2014,GNRL,194795162
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,4.85,10/24/2014,GNRL,202251234
62683,GNRL,"Pfizer Inc.",NY,100000000286,4.82,09/03/2014,GNRL,205473374
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,4.79,09/23/2014,GNRL,202118630
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,4.69,08/07/2014,GNRL,194795098
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,4.68,09/11/2013,GNRL,104292130
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,4.66,01/23/2015,GNRL,269556956
62683,GNRL,"Pfizer Inc.",NY,100000000286,4.59,05/07/2015,GNRL,322863904
62683,GNRL,"LILLY USA, LLC",IN,100000000066,4.58,08/28/2013,GNRL,100135442
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,4.49,10/31/2014,GNRL,194795126
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,4.45,01/28/2015,GNRL,338987612
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,4.44,04/30/2014,GNRL,196807798
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,4.44,07/22/2015,GNRL,338987414
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,4.43,10/24/2013,GNRL,104291232
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,4.41,01/08/2015,GNRL,330119275
62683,GNRL,"Pfizer Inc.",NY,100000000286,4.40,05/15/2014,GNRL,206894354
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,4.40,12/19/2014,GNRL,194795142
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,4.39,02/19/2015,GNRL,269598264
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,4.39,02/09/2015,GNRL,338986244
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,4.38,09/08/2014,GNRL,196806354
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,4.36,09/25/2014,GNRL,196806448
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,4.35,05/13/2014,GNRL,201622348
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,4.33,10/02/2015,GNRL,290546262
62683,GNRL,"Pfizer Inc.",NY,100000000286,4.29,11/14/2013,GNRL,205044948
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,4.29,03/28/2014,GNRL,147123670
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,4.29,02/05/2014,GNRL,201079078
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,4.29,03/09/2015,GNRL,269615100
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,4.29,07/15/2015,GNRL,318662282
62683,GNRL,"LILLY USA, LLC",IN,100000000066,4.25,08/01/2013,GNRL,100147286
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,4.25,12/11/2014,GNRL,196807540
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,4.25,05/22/2014,GNRL,201707054
62683,GNRL,"Pfizer Inc.",NY,100000000286,4.24,09/29/2015,GNRL,323281448
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,4.23,07/16/2014,GNRL,196403314
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,4.18,05/21/2014,GNRL,201710850
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,4.18,03/26/2015,GNRL,269642866
62683,GNRL,"Pfizer Inc.",NY,100000000286,4.14,02/13/2014,GNRL,205882882
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,4.08,08/26/2015,GNRL,318754981
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,4.02,10/29/2015,GNRL,338976802
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,3.90,10/12/2014,GNRL,196806594
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,3.89,05/12/2015,GNRL,319788081
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,3.86,11/02/2015,GNRL,270034854
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,3.84,01/27/2015,GNRL,269568930
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,3.82,06/18/2014,GNRL,196805198
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,3.82,11/03/2015,GNRL,290546254
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,3.81,06/06/2014,GNRL,147123752
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,3.81,10/15/2014,GNRL,196403274
62683,GNRL,"Purdue Pharma L.P.",CT,100000005432,3.80,01/21/2015,GNRL,251068608
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,3.76,08/07/2015,GNRL,330955889
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,3.75,04/01/2015,GNRL,319594453
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,3.73,03/05/2014,GNRL,201346818
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,3.71,03/11/2014,GNRL,201365720
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,3.64,09/02/2014,GNRL,199570474
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,3.64,11/19/2014,GNRL,194795130
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,3.62,09/10/2015,GNRL,290546270
62683,GNRL,"Pfizer Inc.",NY,100000000286,3.59,12/13/2013,GNRL,205163326
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,3.57,05/01/2014,GNRL,196403060
62683,GNRL,"Pfizer Inc.",NY,100000000286,3.55,10/01/2013,GNRL,205704737
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,3.51,01/31/2014,GNRL,201058972
62683,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,3.50,10/21/2015,GNRL,321146072
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,3.42,11/19/2015,GNRL,290546398
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,3.41,10/28/2015,GNRL,318735203
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,3.39,06/19/2014,GNRL,196403320
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,3.38,03/04/2015,GNRL,319640596
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,3.37,01/07/2014,GNRL,199570470
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,3.37,07/03/2014,GNRL,201821394
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,3.36,03/31/2014,GNRL,196804126
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,3.34,02/16/2015,GNRL,330184201
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,3.33,05/14/2015,GNRL,290546292
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,3.26,11/24/2014,GNRL,147123664
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,3.26,10/14/2014,GNRL,199570468
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,3.21,10/29/2015,GNRL,330999245
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,3.17,01/15/2015,GNRL,269559706
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,3.14,06/18/2015,GNRL,330612901
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,3.13,07/16/2014,GNRL,199570466
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,3.11,04/02/2015,GNRL,330387305
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,3.10,04/02/2015,GNRL,338948492
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,3.08,09/16/2015,GNRL,330862819
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,3.04,11/26/2014,GNRL,202509080
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,3.00,07/31/2014,GNRL,196805602
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,2.98,07/09/2015,GNRL,269837678
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,2.92,04/17/2014,GNRL,201512268
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,2.92,05/21/2015,GNRL,269742158
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,2.90,05/27/2014,GNRL,196804736
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,2.90,12/03/2015,GNRL,337427294
62683,GNRL,"Horizon Pharma USA, Inc.",IL,100000005713,2.88,08/05/2013,GNRL,102011152
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,2.86,08/13/2015,GNRL,319334514
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,2.83,11/04/2014,GNRL,199570462
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,2.82,08/05/2015,GNRL,338933598
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,2.72,02/17/2015,GNRL,269599454
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,2.68,11/12/2014,GNRL,147123744
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,2.68,03/05/2015,GNRL,269631882
62683,GNRL,"LILLY USA, LLC",IN,100000000066,2.67,09/18/2013,GNRL,100135184
62683,GNRL,"Pfizer Inc.",NY,100000000286,2.67,05/29/2014,GNRL,206329030
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,2.64,02/23/2015,GNRL,338924716
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,2.62,04/22/2015,GNRL,330485811
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,2.60,07/18/2014,GNRL,196805752
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,2.60,12/03/2014,GNRL,199570460
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,2.60,05/22/2014,GNRL,201679548
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,2.59,08/20/2015,GNRL,330838617
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,2.56,08/26/2014,GNRL,199570458
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,2.55,01/23/2014,GNRL,196803460
62683,GNRL,"Pfizer Inc.",NY,100000000286,2.54,06/25/2015,GNRL,323695376
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,2.52,05/06/2015,GNRL,290546294
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,2.51,05/20/2015,GNRL,330539687
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,2.47,02/27/2015,GNRL,269631802
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,2.45,02/06/2014,GNRL,201106688
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,2.43,02/27/2014,GNRL,202159116
62683,GNRL,"Purdue Pharma L.P.",CT,100000005432,2.43,05/13/2015,GNRL,251095960
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,2.41,06/04/2014,GNRL,202737908
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,2.40,11/16/2015,GNRL,338909092
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,2.38,07/11/2014,GNRL,201878299
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,2.36,04/30/2015,GNRL,269697050
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,2.35,10/08/2015,GNRL,270020244
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,2.33,01/31/2014,GNRL,147123643
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,2.33,09/16/2014,GNRL,194795108
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,2.31,07/16/2015,GNRL,269836093
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,2.30,10/12/2015,GNRL,338901996
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,2.28,01/22/2015,GNRL,330123881
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,2.25,10/20/2015,GNRL,338900800
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,2.23,09/02/2015,GNRL,270010632
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,2.21,10/16/2013,GNRL,104283630
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,2.20,05/15/2014,GNRL,147123780
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,2.15,12/23/2014,GNRL,199570452
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,2.14,12/10/2015,GNRL,290546394
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,2.12,10/30/2014,GNRL,196807100
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,2.07,12/17/2015,GNRL,319794100
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,2.06,08/28/2014,GNRL,196403289
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,2.05,02/19/2015,GNRL,318787487
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,2.04,09/22/2015,GNRL,338896498
62683,GNRL,"Pfizer Inc.",NY,100000000286,2.00,11/04/2015,GNRL,322489332
62683,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,1.99,04/23/2015,GNRL,318932390
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.97,11/06/2014,GNRL,196806758
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.97,12/11/2014,GNRL,196807186
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,1.96,12/23/2014,GNRL,199570449
62683,GNRL,"Pfizer Inc.",NY,100000000286,1.96,04/15/2015,GNRL,323778110
62683,GNRL,"Pfizer Inc.",NY,100000000286,1.92,11/09/2015,GNRL,323882750
62683,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,1.92,08/26/2015,GNRL,321146045
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,1.90,05/08/2014,GNRL,194795180
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,1.86,03/06/2014,GNRL,147123722
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.86,04/15/2014,GNRL,196804402
62683,GNRL,"Pfizer Inc.",NY,100000000286,1.86,08/19/2014,GNRL,207120830
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,1.78,07/09/2015,GNRL,337256688
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.77,10/01/2015,GNRL,270017650
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.77,12/04/2015,GNRL,270077174
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.71,05/31/2015,GNRL,269743252
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,1.71,07/23/2015,GNRL,338887712
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,1.70,03/26/2014,GNRL,194795078
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.67,03/24/2015,GNRL,269635558
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,1.63,09/26/2013,GNRL,104281630
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,1.62,03/28/2014,GNRL,147123686
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,1.60,11/12/2014,GNRL,147123774
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,1.60,11/12/2015,GNRL,290546402
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,1.56,02/07/2014,GNRL,196403082
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,1.56,12/04/2014,GNRL,202532864
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.55,01/15/2015,GNRL,269554328
62683,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,1.51,04/29/2015,GNRL,337120040
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,1.50,09/22/2015,GNRL,338883056
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.48,08/21/2014,GNRL,196805844
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,1.48,11/11/2015,GNRL,290546386
62683,GNRL,"Purdue Pharma L.P.",CT,100000005432,1.43,07/22/2015,GNRL,251021272
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,1.43,03/27/2015,GNRL,330346887
62683,GNRL,"Pfizer Inc.",NY,100000000286,1.42,03/06/2014,GNRL,206749776
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,1.40,10/29/2015,GNRL,338881234
62683,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1.38,09/26/2014,GNRL,149888906
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,1.37,12/11/2014,GNRL,147123733
62683,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,1.34,10/29/2015,GNRL,321146094
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.32,09/22/2014,GNRL,196806428
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.31,06/18/2014,GNRL,196805202
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.29,05/29/2014,GNRL,196804848
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,1.26,02/07/2014,GNRL,147123716
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,1.24,03/19/2014,GNRL,147123710
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.24,01/05/2015,GNRL,269552530
62683,GNRL,"Pfizer Inc.",NY,100000000286,1.19,01/22/2014,GNRL,206667210
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,1.19,03/03/2015,GNRL,330282183
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.17,09/15/2014,GNRL,196806422
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,1.17,12/02/2015,GNRL,331147027
62683,GNRL,"Pfizer Inc.",NY,100000000286,1.10,04/16/2014,GNRL,207325140
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,1.05,08/26/2014,GNRL,199570446
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,0.98,08/05/2015,GNRL,330737721
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,0.96,11/12/2015,GNRL,290546400
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,0.91,11/30/2015,GNRL,331074871
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,0.88,09/29/2014,GNRL,147123657
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.88,10/21/2015,GNRL,270022078
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.85,09/24/2014,GNRL,199570442
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.85,09/15/2015,GNRL,275869558
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.82,07/15/2015,GNRL,269884977
62683,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,0.79,10/14/2015,GNRL,330975201
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.77,09/24/2014,GNRL,199570438
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,0.76,09/08/2015,GNRL,338868484
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,0.72,05/29/2014,GNRL,196403326
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,0.69,11/12/2014,GNRL,147123648
62683,GNRL,"Pfizer Inc.",NY,100000000286,0.68,07/18/2014,GNRL,206397686
62683,GNRL,"LILLY USA, LLC",IN,100000000066,0.66,09/27/2013,GNRL,100145256
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,0.63,12/17/2013,GNRL,104278838
62683,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,0.63,07/29/2014,GNRL,196403306
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,0.63,01/05/2015,GNRL,338865966
62683,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.62,04/07/2014,GNRL,196807948
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,0.62,08/05/2015,GNRL,338865626
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.60,04/16/2015,GNRL,275869566
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,0.58,12/02/2015,GNRL,338864220
62683,GNRL,"Pfizer Inc.",NY,100000000286,0.54,04/10/2014,GNRL,207296784
62683,GNRL,"Pfizer Inc.",NY,100000000286,0.53,11/20/2015,GNRL,323851644
62683,GNRL,"Pfizer Inc.",NY,100000000286,0.51,05/16/2014,GNRL,206467070
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.50,01/23/2014,GNRL,156934336
62683,GNRL,"Actavis Pharma Inc",NJ,100000010642,0.50,06/24/2015,GNRL,338861840
62683,GNRL,"Pfizer Inc.",NY,100000000286,0.49,10/13/2014,GNRL,206304042
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.48,05/01/2014,GNRL,199570434
62683,GNRL,"Pfizer Inc.",NY,100000000286,0.47,10/14/2015,GNRL,323128002
62683,GNRL,"Purdue Pharma L.P.",CT,100000005432,0.46,12/07/2015,GNRL,251154138
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.45,11/20/2014,GNRL,199570430
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.45,04/11/2014,GNRL,199570426
62683,GNRL,"Pfizer Inc.",NY,100000000286,0.45,12/22/2015,GNRL,322729582
62683,GNRL,"LILLY USA, LLC",IN,100000000066,0.44,09/27/2013,GNRL,100145280
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.44,03/06/2014,GNRL,156934342
62683,GNRL,"LILLY USA, LLC",IN,100000000066,0.43,08/15/2013,GNRL,100077918
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.43,09/09/2014,GNRL,156934362
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.41,05/12/2014,GNRL,156934350
62683,GNRL,"Pfizer Inc.",NY,100000000286,0.41,06/05/2015,GNRL,322990864
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.39,01/17/2014,GNRL,156934338
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.39,06/05/2014,GNRL,199570422
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.39,06/27/2014,GNRL,199570418
62683,GNRL,"Pfizer Inc.",NY,100000000286,0.39,09/22/2014,GNRL,206565406
62683,GNRL,"Pfizer Inc.",NY,100000000286,0.39,09/15/2014,GNRL,205629384
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.38,11/26/2014,GNRL,199570414
62683,GNRL,"Pfizer Inc.",NY,100000000286,0.37,01/13/2015,GNRL,322995190
62683,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.35,10/09/2014,GNRL,199570412
62683,GNRL,"Pfizer Inc.",NY,100000000286,0.34,12/13/2013,GNRL,205537938
62683,GNRL,"Purdue Pharma L.P.",CT,100000005432,0.33,04/01/2015,GNRL,251060224
62683,GNRL,"Pfizer Inc.",NY,100000000286,0.33,11/23/2015,GNRL,322806366
62683,GNRL,"Pfizer Inc.",NY,100000000286,0.33,01/22/2015,GNRL,323909972
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,0.32,02/24/2014,GNRL,147123704
62683,GNRL,"Pfizer Inc.",NY,100000000286,0.30,01/22/2014,GNRL,206220312
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.30,09/04/2015,GNRL,275869578
62683,GNRL,"Pfizer Inc.",NY,100000000286,0.30,09/23/2015,GNRL,323811202
62683,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,0.29,07/07/2014,GNRL,147123698
62683,GNRL,"Pfizer Inc.",NY,100000000286,0.29,11/10/2014,GNRL,205576240
62683,GNRL,"Pfizer Inc.",NY,100000000286,0.29,02/06/2015,GNRL,322718554
62683,GNRL,"Purdue Pharma L.P.",CT,100000005432,0.25,01/21/2015,GNRL,251068562
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.25,07/16/2015,GNRL,275869574
62683,GNRL,"Pfizer Inc.",NY,100000000286,0.24,07/31/2014,GNRL,206063022
62683,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,0.24,10/29/2015,GNRL,321146082
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.23,05/07/2015,GNRL,275869570
62683,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.22,08/08/2014,GNRL,156934360
62683,GNRL,"Pfizer Inc.",NY,100000000286,0.20,11/01/2013,GNRL,205919719
62683,GNRL,"Pfizer Inc.",NY,100000000286,0.10,04/17/2015,GNRL,323458728
